Tag Archives: Johnson & Johnson

CDC Panel Recommends Lifting Pause On J&J Vaccine

Courthouse News reports: An independent advisory panel for the U.S. Centers for Disease Control and Prevention voted Friday to recommend the continued use of the Johnson & Johnson Covid-19 vaccine after the single-dose jab was put on pause over blood clotting concerns. Friday’s vote followed similar concerns in the Europe Union over both the J&J jab and the AstraZeneca vaccine, …

Read More »

CDC Calls For Immediate Pause In Use Of J&J Vaccine

The New York Times reports: Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. All six recipients were women between the ages of 18 and 48. One woman died and …

Read More »

Biden To Secure Another 100 Million J&J Vaccine Doses

The Washington Post reports: President Biden intends to announce Wednesday that his administration will secure an additional 100 million doses of the single-shot vaccine developed by Johnson & Johnson, according to two officials familiar with the matter. He is expected to preview the plans at a Wednesday meeting with executives from Johnson & Johnson and Merck, just over a week …

Read More »

Biden To Announce “Historic Partnership” In Which Merck Will Help J&J Manufacture And Distribute Vax

The Washington Post reports: President Biden will announce Tuesday that pharmaceutical giant Merck & Co. will help make Johnson & Johnson’s single-shot coronavirus vaccine — an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials. Under the arrangement, Merck will dedicate two facilities in the United States to …

Read More »

FDA Approves Use Of J&J’s Single-Shot COVID Vaccine

The New York Times reports: The Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-shot Covid-19 vaccine for emergency use, beginning the rollout of millions of doses of a third effective vaccine that could reach Americans by early next week. The announcement arrived at a critical moment, as the steep decline in coronavirus cases seems to have plateaued …

Read More »

FDA Panel Approves Single-Shot J&J COVID Vaccine

NBC News reports: An independent advisory panel to the Food and Drug Administration voted Friday to recommend that the agency authorize Johnson & Johnson’s Covid-19 vaccine. Members of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted unanimously in favor of recommending authorization. The FDA is not required to go along with the committee’s recommendation, but is widely …

Read More »

FDA Confirms Efficacy Of J&J’s Single-Shot Vaccine

CNBC reports: The Food and Drug Administration’s staff endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use, a critical step in bringing a third shot to the U.S. marketplace. The staff report released Wednesday is meant to brief the FDA’s Vaccines and Related Biological Products Advisory Committee, which will meet Friday to review J&J’s request for emergency use authorization. The …

Read More »

J&J Seeks FDA Approval For Its Single-Shot Vaccine

The Associated Press reports: Johnson & Johnson asked U.S. regulators late Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies. J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19, according to preliminary results from a massive international study. It didn’t appear quite as strong as two-dose competitors made …

Read More »

Trial Result: J&J Single-Shot Vaccine Is 66% Effective

The Wall Street Journal reports: Johnson & Johnson said its experimental Covid-19 vaccine was 66% effective at protecting people from moderate to severe disease in a large clinical trial, positive results that could pave the way for its deployment across the U.S. within weeks. The J&J vaccine also appeared to be generally safe and well tolerated among the 44,325 adults …

Read More »

J&J Begins Final Trial Of Single-Shot COVID Vaccine

Reuters reports: Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses. The company expects results of the Phase III trial by year end or early next year, Dr. Paul Stoffels, J&J’s chief scientific officer, said in a …

Read More »

J&J Starts Human Trials On Single-Dose COVID Vaccine

Reuters reports: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose. When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and …

Read More »

Pharma Giant Discontinues Baby Powder Amid Lawsuits

CNBC reports: Johnson & Johnson said Tuesday that it is discontinuing its talc-based baby powder in the United States and Canada as demand fell in light of mounting lawsuits that said it caused cancer. J&J attributed the decline “in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage …

Read More »

Major Pharma To Begin Virus Vaccine Trial In September

Mediaite reports: Johnson & Johnson announced Monday that the first candidate for its experimental coronavirus vaccine has been selected, and trials will begin by September. J&J also said that if the first phase of testing goes as planned, the vaccine could be ready for administration under emergency authorization beginning in early 2021. This is much earlier than the usual 18-month …

Read More »